RECURRENT PLASMA CELL MYELOMA
Clinical trials for RECURRENT PLASMA CELL MYELOMA explained in plain language.
Never miss a new study
Get alerted when new RECURRENT PLASMA CELL MYELOMA trials appear
Sign up with your email to follow new studies for RECURRENT PLASMA CELL MYELOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Radioactive antibody zaps Hard-to-Treat myeloma in early trial
Disease control Recruiting nowThis early-phase study tests a new combination treatment for multiple myeloma that has returned or stopped responding to standard therapy. The treatment uses a radioactive molecule attached to an antibody (daratumumab) to deliver radiation directly to cancer cells. About 15 adult…
Matched conditions: RECURRENT PLASMA CELL MYELOMA
Phase: PHASE1 • Sponsor: City of Hope Medical Center • Aim: Disease control
Last updated May 01, 2026 15:26 UTC
-
Engineered immune cells take aim at Hard-to-Treat myeloma
Disease control Recruiting nowThis early-phase study tests a new treatment for adults with a type of blood cancer called multiple myeloma that has returned or stopped responding to standard therapy. The treatment involves taking a patient's own immune cells, modifying them in a lab to recognize and attack the…
Matched conditions: RECURRENT PLASMA CELL MYELOMA
Phase: PHASE1 • Sponsor: City of Hope Medical Center • Aim: Disease control
Last updated Apr 29, 2026 15:01 UTC